MMP11 and neoplasm: Subtype 2 exhibited significantly higher stromal and immune scores, ESTIMATE scores, MMP11+ mCAF signature scores, and proportions of MMP11+ mCAFs compared to Subtype 1, along with notably lower tumor purity (Figure S4B, Supporting Information).